Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
about
Assessment of three epigenotypes in colorectal cancer by combined bisulfite restriction analysis.RASSF1A promoter hypermethylation is a strong biomarker of poor survival in patients with salivary adenoid cystic carcinoma in a Chinese population.From genotype to functional phenotype: unraveling the metabolomic features of colorectal cancer.Butyrate-rich colonic microenvironment is a relevant selection factor for metabolically adapted tumor cells.Irrelevance of microsatellite instability in the epidemiology of sporadic pancreatic ductal adenocarcinomaDistinct profiles of epigenetic evolution between colorectal cancers with and without metastasis.Immunohistochemistry - microarray analysis of patients with peritoneal metastases of appendiceal or colorectal originAberrant promoter methylation of RASSF1A gene may be correlated with colorectal carcinogenesis: a meta-analysis.Biomarkers of cervical dysplasia and carcinomaAberrant methylation of ERBB pathway genes in sporadic colorectal cancer.Clinical utility of RASSF1A methylation in human malignancies.Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.RAS signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1ALoss of RASSF1A expression in colorectal cancer and its association with K-ras status.Metachronous pancreatic head ductal carcinoma three years after resection of gallbladder cancer.Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response.Diminished expression of MGMT & RASSF1A genes in gastric cancer in ethnic population of KashmirA genetic variant in Rassf1a predicts outcome in mCRC patients treated with cetuximab plus chemotherapy: results from FIRE-3 and JACCRO 05 and 06 trials.Colorectal cancer and RASSF family--a special emphasis on RASSF1A.Natural history of hepatic metastases from colorectal cancer--pathobiological pathways with clinical significance.Loss of E-cadherin expression predicts disease recurrence and shorter survival in colorectal carcinoma.MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway.A role for iron in Wnt signalling.Histopathological and genetic differences between polypoid and non-polypoid submucosal colorectal carcinoma.Genetic and epigenetic alterations in primary colorectal cancers and related lymph node and liver metastases.Molecular staging of colorectal cancer: new paradigm or waste of time?Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.High frequency of genes' promoter methylation, but lack of BRAF V600E mutation among Iranian colorectal cancer patients.Promoter methylation of the RASSF1A gene may contribute to colorectal cancer susceptibility: a meta-analysis of cohort studiesPrognostic Values of EPDR1 Hypermethylation and Its Inhibitory Function on Tumor Invasion in Colorectal CancerMolecular characteristics of colorectal cancer in a Middle Eastern population in a single institution
P2860
Q34050217-C3332C40-4DC7-4076-8058-99F3E88608A8Q34323619-A94FFA75-A7E9-4621-A5F9-D62C7BC165E2Q34347646-84EA3E44-2034-4360-BE18-7B5111FA5D0CQ34385792-FB20187E-E1B3-4F3B-8241-A9C94D1F406AQ34430572-5913BD89-F85D-4865-AB78-22D14721FF8DQ34805590-A80A834E-74CD-446D-A8F1-6EEDE17BAE40Q34867868-D22345A3-9404-49FE-B249-17C0E43E52D5Q35102447-D6DD78C2-43D0-4076-993D-6451318529D8Q35495173-9B8BCB5D-C207-4D86-A572-B786E965CCE5Q35546945-486EE74B-521B-4BFA-A582-5C3D7052B47AQ35909621-E21ECDA4-6667-4D9B-AECF-664DCDCFB5DCQ36610632-E1091C9E-66B6-4825-8B66-8AE27AE5EE57Q36730389-CA2317E7-DC2B-450C-B31A-E5A84D90B7F1Q36995731-6A5E1838-77CF-4020-B497-FD8E5507E451Q37233512-1DE0E2F8-514C-44FB-9536-2FD33695E26BQ37346216-CADF9BAF-05C4-40B6-9920-364AB7E42D36Q37525373-8AACD245-2A97-4B05-8A43-A6DFEA3FE335Q37735989-6D3C2ACE-FFA8-4D19-B360-AE51D953DF0DQ38021701-42746082-C842-4E10-886D-19108693B28BQ38205428-3A7C1EB4-E7D5-4C65-8836-7F358472E0DDQ38402754-6C90F048-F24A-4C72-AAD7-30BFEDF64449Q38927984-3A72EBCC-B762-4220-ADBF-163AAEC306F2Q40093509-4BE7A6B0-CCBE-498F-B29E-ACFA38A1B55BQ43135094-125AAEDF-0725-40A1-8658-29F08B67ADE9Q45353745-3955B2C3-D3EE-4FC4-8120-B2F1D2A405C9Q48690676-2EE63E14-642C-4F62-8FE6-274BC2B1E602Q54232902-BE0943F1-C708-4D21-9B7C-FFE0D3A05248Q54599602-AEBC9A69-E9B7-4EC9-9846-75A987D0B14FQ56519160-D63C38DD-2768-41E2-B8FD-EF726710F6BEQ58579211-1E7C2E2C-F418-44F0-A5C7-ED675C33ADA2Q58803324-96BB5303-18F6-4169-9D6C-029122B397AD
P2860
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
@ast
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
@en
type
label
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
@ast
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
@en
prefLabel
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
@ast
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer.
@en
P2093
P2860
P50
P356
P1476
Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer
@en
P2093
E Balladore
E Morenghi
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603337
P407
P577
2006-09-12T00:00:00Z